PROJECT

Projects

Summary of Investment Information

Project Number

35989

Company Name

REGENCY HOSPITAL LIMITED

Date SPI Disclosed

Apr 14, 2016

Country

India

Region

South Asia

Projected Board Date

May 20, 2016

Environmental Category

B - Limited

Status

Completed

Last Updated Date

Jan 12, 2024

Department

Regional Industry - MAS Asia & Pac

Industry

Health, Education and Life Sciences

Previous Events

Approved : Jun 20, 2016
Signed : Sep 13, 2016
Invested : Feb 16, 2017

Sector

Hospitals and Clinics

Project Description

Regency Hospital Limited (“Regency” or the “Company”) is a healthcare service provider in Kanpur, the largest city of the state of Uttar Pradesh (“UP”), a Low- Income-State (LIS) in India. Established in 1989 and promoted by Dr. Atul Kapoor and Dr. Rashmi Kapoor, Regency owns and operates a network which includes: two tertiary care hospitals (a 175 bed multi-specialty hospital and a 75 bed renal care super-specialty hospital); a healthcare clinic providing outpatient and diagnostic services; and dialysis treatment centers operated under a joint venture with Fresenius Medical Care, the world’s largest provider of products and services to people with chronic kidney failure.

The proposed project (the “Project”) would increase the number of operational beds by 550 beds through organic expansion in the state of UP, which is one of the most underserved regions in terms of healthcare infrastructure. The project will include completion and opening of operations for a secondary care hospital and an oncology hospital, both in Kanpur. The oncology hospital will be the first cancer treatment center hospital in the state of UP, and will be operated under a joint venture between Regency and Health Care Global (HCG), India’s largest specialist cancer treatment provider. The project will support Regency to add multi-specialty, renal and dialysis, and oncology care facilities in other cities of central and eastern UP, under its own brand and through the joint ventures with Fresenius and HCG.

Associated Advisory Engagement

N/A

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation